RxSight (NASDAQ:RXST) Given New $61.00 Price Target at Oppenheimer
RxSight (NASDAQ:RXST – Get Free Report) had its price objective increased by analysts at Oppenheimer from $54.00 to $61.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price target points to a potential upside of 8.73% from the stock’s […]